Skip to content

Micro-tissue biopsy helps in the early detection of endometrial cancer

Research on the Application Value of Micro-tissue Biopsy in Endometrial Cancer Screening

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124348
Enrollment
Unknown
Registered
2026-05-11
Start date
2025-09-29
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial carcinoma

Interventions

Index test:Microbiopsy pathological diagnosis, immunohistochemical results, methylation results

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women who are scheduled to undergo hysteroscopy or curettage for pathological diagnosis due to high-risk factors for endometrial cancer such as abnormal uterine bleeding and uterine cavity space-occupying lesions; 2. Have complete clinical data and follow-up information; 3. All subjects are required to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Acute or subacute genital inflammation or pelvic inflammatory disease; 2. Pregnancy or suspected pregnancy; 3. Confirmed or suspected intrauterine device; 4. Uterine perforation; 5. People who are allergic to ABS resin, polycarbonate PC and polyamide (nylon).

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;Positive Predictive Value;Negative Predictive Value;

Countries

China

Contacts

Public ContactYuhong Ye

The First Affiliated Hospital of Fujian Medical University

yeyuhong519@163.com+86 591 8798 1654

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026